Abstract
Fungal infections are less common than bacterial or viral infections and are associated with a high rate of morbidity and mortality. This text will discuss infections by Aspergillus in their different clinical symptoms, histoplasmosis, and coccidioidomycosis. The diagnosis is determined by compatible symptoms, characteristic risk factors, radiological findings, and microbiological isolation. There are a wide variety of prophylaxis and antifungal treatment strategies. Antifungal treatment in aspergillosis and other types of pulmonary mycoses are based on the use of liposomal amphotericin B, echinocandins, and azoles, all based on the isolation of the described species and resistances. This type of treatment has different profiles of effectiveness, safety, pharmacological interactions, and important side effects to take into account.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
